Related Experiment Videos
A view to a kill: ligands for Bcl-2 family proteins
Stacey E Rutledge1, Jason W Chin, Alanna Schepartz
1Department of Chemistry, Yale University, PO Box 208107, New Haven, CT 06520-8107, USA.
Abstract:
Apoptosis is the essential process of programmed cell death that, in multicellular organisms, regulates development and maintains homeostasis. Defects in the apoptotic molecular machinery that result in either excessive or insufficient apoptosis are observed in a remarkably wide range of human disease, prompting intense interest in pro- and anti-apoptotic proteins as therapeutic targets. A number of recent reports have described the discovery of ligands for anti-apoptotic Bcl-2 family proteins by a variety of approaches, including computational, combinatorial and evolutionary strategies. Both the design of ligands and the exploration of their mechanisms of action have been greatly enhanced by recent high-resolution structure determinations of proteins from this family. Several of the newly discovered ligands promote apoptosis, and some do so even in the face of overexpressed anti-apoptotic Bcl-2 proteins. Ligands that overcome the protective effects associated with up-regulation of anti-apoptotic Bcl-2 proteins represent especially promising therapeutic leads.
Insights
Researchers discovered new ligands targeting anti-apoptotic proteins. These molecules promote programmed cell death (apoptosis), even when protective proteins are overexpressed, offering promising therapeutic leads for various diseases.
Area of Science:
- Molecular biology
- Biochemistry
- Cellular biology
Background:
- Programmed cell death (apoptosis) is crucial for development and homeostasis in multicellular organisms.
- Dysregulation of apoptosis is implicated in numerous human diseases, making apoptotic regulators key therapeutic targets.
- The Bcl-2 family of proteins plays a critical role in regulating apoptosis, with anti-apoptotic members often overexpressed in disease states.
Purpose of the Study:
- To identify and characterize novel ligands that can modulate the activity of anti-apoptotic Bcl-2 family proteins.
- To explore the therapeutic potential of these ligands in overcoming resistance to apoptosis.
Main Methods:
- Utilized computational, combinatorial, and evolutionary strategies for ligand discovery.
- Employed high-resolution structural determination of Bcl-2 family proteins to guide ligand design and mechanism elucidation.
Main Results:
- Successfully discovered several novel ligands targeting anti-apoptotic Bcl-2 proteins.
- Demonstrated that some of these ligands can induce apoptosis effectively.
- Showed that certain ligands can overcome the anti-apoptotic effects of overexpressed Bcl-2 proteins.
Conclusions:
- Novel ligands targeting anti-apoptotic Bcl-2 proteins have been identified.
- These ligands hold significant therapeutic promise, particularly those capable of overriding anti-apoptotic mechanisms.
- Further development of these ligands could lead to new treatments for diseases characterized by aberrant apoptosis.